Investors are closely monitoring several under-$1 Nasdaq-listed stocks delivering key updates and financial milestones this week:

CytomX Therapeutics, Inc. (NASDAQ: CTMX) surged in pre-market after announcing the pricing of a $100 million underwritten public offering. The company is issuing 76.9 million shares at $1.30 each to fund R&D and working capital. Backed by leading biotech investors such as Longitude Capital, OrbiMed, Venrock, and RTW, the offering is set to close May 13, 2025.

Jayud Global Ltd. (NASDAQ: JYD) continues building out its cross-border logistics empire. With operations in 16 countries and 12 Chinese provinces, JYD is leveraging Shenzhen’s strategic location to dominate global freight and supply chain logistics.

Health In Tech (NASDAQ: HIT) made headlines with the appointment of former U.S. Ambassador Edward T. McMullen Jr. to its new advisory board. CEO Tim Johnson also highlighted the company’s 56% revenue growth and AI-powered health platform on Listen to Podcast Now!

Gryphon Digital Mining (NASDAQ: GRYP) is releasing earnings today as interest in carbon-negative Bitcoin mining continues to rise. Investors are watching closely as Gryphon’s clean-energy blockchain strategy gains institutional momentum.

Taoping Inc. (NASDAQ: TAOP), active in cloud-based display and IoT solutions for sectors ranging from healthcare to education, remains on watch amid renewed interest in smart infrastructure and digital transformation tech.

WANG & LEE GROUP Inc. (NASDAQ: WLGS) provides essential MVAC and safety systems for infrastructure projects across Asia. As construction season heats up, WLGS may gain momentum from regional project demand and utility upgrades.

Peraso Inc. (NASDAQ: PRSO), a semiconductor leader in mmWave tech, is scheduled to release Q1 earnings after the close. Analysts project a $0.16 per-share loss, marking an 80.7% year-over-year improvement. Revenue is expected to rise 34% to $3.78 million as the company expands its PERSPECTUS wireless infrastructure line. See Earnings Preview

With major earnings reports, strategic appointments, and capital raises making waves, these sub-$1 stocks are drawing increased attention from both institutional and retail investors. As market sentiment pivots toward high-upside, low-entry opportunities, names like CTMX, HIT, GRYP, TAOP, JYD, WLGS and PRSO stand out with tangible catalysts in motion. Investors seeking momentum plays in biotech, semiconductor, digital health, and crypto infrastructure should keep a close watch on these undervalued tickers as the week unfolds.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com